601607 fundamentals
An in-depth look to SHANGHAI PHARMACEUTICALS HOLDING operating, investing, and financing activities
601607 free cash flow for Q1 24 is -6.22 B CNY. For 2023, 601607 free cash flow was 3.24 B CNY and operating cash flow was 6.21 B CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM